Henk Stunnenberg’s lab experiences feed back into Genomatix’ further developments.

Munich, Germany – Genomatix Software, the leading provider of solutions for the comprehensive analysis of Next Generation Sequencing (NGS) data, announced today that the Nijmegen Centre for Molecular Life Sciences (NCMLS) installed a Genomatix Genome Analyzer (GGA) at Henk Stunnenberg’s lab. Henk Stunnenberg, a pioneer in transcription factor analysis and epigenetic research, is full professor, head of the Department of Molecular Biology, and a member of EMBO.

The Genomatix Genome Analyzer delivers a complete and integrated solution for the downstream analysis of NGS data. Rich biological background knowledge, integrated in databases and comprehensive software tools, enable a molecular level understanding of the biology being studied within a few hours.

“The GGA has the advantage of incorporating all of the renowned software and data content Genomatix has built over the past 11 years, and putting an excellent NGS overlay on it all” says Prof. Dr. Henk Stunnenberg. “This allows us to drill down into the biology of our systems in an easy to use workflow environment with all their terrific science in the background”.

Martin Seifert, Chief Executive for Marketing and Consulting at Genomatix, says: “I am very proud that Dr. Stunnenberg has chosen our system. With our combined hardware/software approach, we are able to get the most out of data from Next Generation Sequencing experiments in surprisingly short time. Especially in the field of ChIP-Seq and RNA sequencing, thus shortening the time to publication significantly. For Dr. Stunnenberg’s group, with its many brilliant scientists, our integrated systems are greatly facilitating their data analysis process. We are really pleased that the response from the group is very positive, and their feedback will contribute substantially in helping to define the direction of further developments of our technology at Genomatix”.

The Nijmegen Centre for Molecular Life Sciences (NCMLS) is a leading multidisciplinary research school within the domain of molecular mechanisms of disease and particularly in the fields of molecular medicine, cell biology and translational research. The research is focused in keeping with the mission towards understanding the cellular basis of disease. Henk Stunnenberg’s research interest is in the unraveling of the molecular basis of cell behaviour emanating from the genetic and epigenetic code contained in the nucleus in the context of health and disease

Genomatix Software GmbH is a computational biology company headquartered in Munich, Germany with a seat of business in Ann Arbor, MI, U.S.A. Founded in 1997, Genomatix pioneered the analysis and understanding of eukaryotic gene regulation. Over a decade of developments in computational and systems biology has put Genomatix into position to have a complete analysis pipeline in place at the arrival of next generation sequencing technology. Genomatix has published more than 180 peer reviewed scientific papers with more than 5,000 citations. Over 35,000 researchers worldwide currently apply Genomatix tools and databases.

More information is available from https://www.genomatix.de or https://www.genomatix-software..com.